Open access
AA amyloidosis in the four historical monogenic autoinflammatory diseases: Clinical burden and insights from a retrospective referral‐centre study
Majdouline El Moussaoui
L. Savey
Hassina Sofia Aloui-Belhocine
J. Boffa
M. Delplanque
C. Grandpeix-Guyodo
I. Giurgea
L. Cuisset
G. Boursier
G. Grateau
D. Buob
S. Georgin-lavialle
Medicine
Abstract
AA amyloidosis (AAA) remains a life‐threatening yet largely preventable complication of monogenic autoinflammatory diseases (AIDs).